Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Indegene Limited ( (IN:INDGN) ) has provided an update.
Indegene Limited has announced that its shareholders have approved, via a postal ballot conducted through remote e-voting, a special resolution appointing Mr. Neeraj Bharadwaj as an Independent Director of the company. The voting process, carried out in compliance with SEBI listing regulations and the Companies Act, reflects the company’s ongoing efforts to strengthen its board with independent oversight, a move that may enhance corporate governance standards and support strategic decision-making as Indegene continues to scale its operations in the healthcare and life sciences services market.
More about Indegene Limited
Indegene Limited is an India-based company operating in the healthcare and life sciences services space, providing technology-enabled solutions and services to pharmaceutical and biotech clients worldwide. The company focuses on leveraging digital, data, and analytics capabilities to support commercial, medical, and regulatory operations for its global customer base.
Average Trading Volume: 11,842
Technical Sentiment Signal: Sell
Current Market Cap: 115.1B INR
See more insights into INDGN stock on TipRanks’ Stock Analysis page.